About
Technology
Issues
FAQ
Links
Official Page
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.